Any further upside for the Hang Seng will be limited, says Peter Lai, director at DBS Vickers Securities. He shares his outlook for the Hong Kong market, with CNBC's Martin Soong & Saijal Patel.
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.
Douglas Roberts, of ChannelCapitalResearch.com, and Dean Barber, of the Barber Financial Group, share their investment strategies and favorite sectors with CNBC.